Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global BA Market Portraiture
2.2. Global BA Market, by Type, 2017 (US$ Mn)
2.3. Global BA Market, by Application, 2017 (US$ Mn)
2.4. Global BA Market, by Geography, 2017 (US$ Mn)
Chapter 3. BA Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global BA Market, by Key Players, 2017
Chapter 4. Global BA Market, by Type
4.1. Overview
4.2. Immunoglobulin G (IgG) Like Molecule
4.3. Non Immunoglobulin G (IgG) Like Molecule
Chapter 5. Global BA Market, by Application
5.1. Overview
5.2. Oncology
5.3. Autoimmune Disease
5.4. Others
Chapter 6. Global BA Market, by Geography
6.1. Overview
6.2. North America BA Market Analysis, 2016 – 2026
6.2.1. North America BA Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America BA Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America BA Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe BA Market Analysis, 2016 – 2026
6.3.1. Europe BA Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe BA Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe BA Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific BA Market Analysis, 2016 – 2026
6.4.1. Asia Pacific BA Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific BA Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific BA Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America BA Market Analysis, 2016 – 2026
6.5.1. Latin America BA Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America BA Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America BA Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa BA Market Analysis, 2016 – 2026
6.6.1. MEA BA Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA BA Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA BA Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Amgen, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Type Portfolio
7.1.4. News Coverage
7.2. Ablynx
7.3. Eli Lilly and Company
7.4. F. Hoffmann-La Roche AG
7.5. Janssen Global Services, LLC
7.6. Merck Group
7.7. Merrimack Pharmaceuticals
7.8. Neovii Biotech
7.9. OncoMed Pharmaceuticals, Inc.
7.10. Regeneron Pharmaceuticals
List of Figures
FIG. 1 Bispecific Antibodies (BA) Market: Research Methodology
FIG. 2 BA Market Segmentation
FIG. 3 Global BA Market, by Type, 2017 (US$ Mn)
FIG. 4 Global BA Market, by Application, 2017 (US$ Mn)
FIG. 5 Global BA Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global BA Market, by Key Players, 2017
FIG. 8 Global IgG Like Molecule Market for Bispecific Antibodies, 2016 – 2026 (US$ Mn)
FIG. 9 Global Non IgG Like Molecule Market for Bispecific Antibodies, 2016 – 2026 (US$ Mn)
FIG. 10 Global Oncology Market for Bispecific Antibodies, 2016 – 2026 (US$ Mn)
FIG. 11 Global Autoimmune Disease Market for Bispecific Antibodies, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Applications Market for Bispecific Antibodies, 2016 – 2026 (US$ Mn)
FIG. 13 U.S. BA Market, 2016 – 2026 (US$ Mn)
FIG. 14 Canada BA Market, 2016 – 2026 (US$ Mn)
FIG. 15 U.K. BA Market, 2016 – 2026 (US$ Mn)
FIG. 16 Germany BA Market, 2016 – 2026 (US$ Mn)
FIG. 17 Rest of Europe BA Market, 2016 – 2026 (US$ Mn)
FIG. 18 China BA Market, 2016 – 2026 (US$ Mn)
FIG. 19 Japan BA Market, 2016 – 2026 (US$ Mn)
FIG. 20 Rest of Asia Pacific BA Market, 2016 – 2026 (US$ Mn)
FIG. 21 Brazil BA Market, 2016 – 2026 (US$ Mn)
FIG. 22 Mexico BA Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest of Latin America BA Market, 2016 – 2026 (US$ Mn)
FIG. 24 GCC BA Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of MEA BA Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global Bispecific Antibodies (BA) Market Portraiture
TABLE 2 Global BA Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global BA Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global BA Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America BA Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America BA Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America BA Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe BA Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe BA Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe BA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific BA Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific BA Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific BA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America BA Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America BA Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America BA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa BA Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa BA Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa BA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Amgen, Inc.: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 21 Ablynx: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 22 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 23 F.Hoffman-La Roche AG: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 24 Janssen Global Services, LLC.: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 25 Merck Group: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 26 Merrimack Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 27 Neovii Biotech: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 28 OncoMed Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)
TABLE 29 Regeneron Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Application Portfolio; Key Developments)